Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

The Lancet Neurology

Volumn 9, Issue 5, 2010, Pages 481-488

  Aggarwal, Swati P ^a   Zinman, Lorne ^b   Simpson, Elizabeth ^a   McKinley, Jane ^b   Jackson, Katherine E ^a   Pinto, Hanika ^b   Kaufman, Petra ^c   Conwit, Robin A ^c   Schoenfeld, David ^a   Shefner, Jeremy ^d   Cudkowicz, Merit ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d State University New York College of Environmental Science and Forestry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; DYSPNEA; FALLING; FASCICULATION; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NAUSEA; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUG TOXICITY; HUMANS; INTENTION TO TREAT ANALYSIS; LITHIUM; MALE; MEDICAL FUTILITY; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RILUZOLE; TREATMENT OUTCOME;

EID: 77950628380     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70068-5     Document Type: Article

References (23)

1. Fornai F., Longone P., Cafaro L., et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 105 (2008) 2052-2057
2. Fornai F., Longone P., Ferrucci M., et al. Autophagy and amyotrophic lateral sclerosis: the multiple roles of lithium. Autophagy 4 (2008) 527-530
3. Sarkar S., Floto R., Berger Z., et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170 (2005) 1101-1111
4. Sarkar S., and Rubinsztein D.C. Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations. Autophagy 2 (2006) 132-134
5. Nonaka S., Hough C.J., and Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 95 (1998) 2642-2647
6. Shin J.H., Cho S.I., Lim H.R., et al. Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. Mol Pharmacol 71 (2007) 965-975
7. Feng H.L., Leng Y., Ma C.H., Zhang J., Ren M., and Chuang D.M. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155 (2008) 567-572
8. Dill J., Wang H., Zhou F., and Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci 28 (2008) 8914-8928
9. Su H., Zhang W., Guo J., Guo A., Yuan Q., and Wu W. Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem 108 (2009) 1385-1398
10. Filimonenko M., Stuffers S., Raiborg C., et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol 179 (2007) 485-500
11. Brooks B. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis.". J Neurol Sci 124 (1994) 96-107
12. Cedarbaum J., Stambler N., Malta E., et al. The ALSFRS-R: a revised ALS functional rating scale that incorporated assessments of respiratory function. J Neurol Sci 169 (1999) 13-21
13. Miano B., Stoddard G., Davis S., and Bromberg M. Inter-evaluator reliability of the ALS functional rating scale. Amyotroph Lateral Scler Other Motor Neuron Disord 5 (2004) 235-239
14. Kasarskis E.J., Dempsey-Hall L., Thompson M.M., Lan Chi L., Mendiondo M., and Kryscio R. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 6 (2005) 50-54
15. Simmons Z., Felgoise S.H., Bremer B.A., et al. The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology 67 (2006) 1659-1664
16. Rush A.J., Trivedi M.H., Ibrahim H.M., et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54 (2003) 573-583
17. Trivedi M.H., Rush A.J., Ibrahim H.M., et al. The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 34 (2004) 73-82
18. Jennison C., and Turnbull B.W. Flexible monitoring: the error spending approach. Group sequential methods with applications to clinical trials (2000), Chapmann & Hall/CRC, NY 145-169
19. Schoenfeld D.A. A simple algorithm for designing group sequential clinical trials. Biometrics 57 (2001) 972-974
20. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
21. Su H., Chu T.H., and Wu W. Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol 206 (2007) 296-307
22. Perry P.J., Alexander B., Dunner F.J., Schoenwald R.D., Pfohl B., and Miller D. Pharmacokinetic protocol for predicting serum lithium levels. J Clin Psychopharmacol 2 (1982) 114-118
23. Cudkowicz M.E., Shefner J.M., Schoenfeld D.A., et al. Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol 60 (2006) 22-31